![](https://porib.com/wp-content/uploads/2021/07/the_european_journal_of_hospital_pharmacy___science_and_practice.jpg)
Montalar J, Cajaraville G, Carreras MJ, Rubio MJ, García-San Andrés B, Oyagüez I, Casado MA
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD monotherapy in relapsed platinum-sensitive ovarian cancer patients: a cost-effectiveness analyses in Spain
Eur J Hosp Pharmacy. 2012;19:364-69
![](https://porib.com/wp-content/uploads/2021/07/applied_health_economics_and_health_policy.jpg)
Roman A, Barberà JA, Escribano P, Sala ML, Febrer L, Oyagüez I, Sabater E, Casado MA
Cost effectiveness of prostacyclins in pulmonary arterial hypertension
Appl Health Econ Health Policy. 2012;10(3):175-88
![](https://porib.com/wp-content/uploads/2021/07/health_economics_review-2.jpg)
García-Ruiz A, Perez-Costillas L, Montesinos AC, Alcalde J, Oyagüez I, Casado MA
Efficiency of antipsychotics in reducing schizophrenia relapses
Health Econ Rev. 2012;2:8
![](https://porib.com/wp-content/uploads/2021/07/bmc_infectious_diseases.jpg)
Grau S, de la Camara R, Sabater FJ, Jarque I, Carreras E, Casado MA, Sanz MA
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
BMC Infect Dis. 2012;12:83 doi:10.1186/1471-2334-12-83
![](https://porib.com/wp-content/uploads/2007/01/enfermedades-infecciosas-y-microbiologia-clinica.jpg)
García-Jurado L, Oyagüez I, Casado MA, Tural C, González García J, Ortega E, Pineda JA
Evaluación Económica de la Elastografía de Transición (FibroScan®) en el diagnóstico de fibrosis hepática en pacientes con hepatitis C coinfectados con VIH
Enferm Infecc Microbiol Clin. 2012;30(6):294-9
![](https://porib.com/wp-content/uploads/2021/07/journal_of_medical_economics.jpg)
Sánchez-de la Rosa R, Sabater E, Casado MA, Arroyo R
Cost-effectiveness analysis of disease modifiying drugs (interferons and glatiramer acetate) as first line treatments in remitting-relapsing multiple sclerosis patients
J Med Econ. 2012;15(3):1–10
González-Juanatey JR, Álvarez-Sabin J, Lobos JM, Martínez-Rubio A, Reverter JC, Oyagüez I, González-Rojas N, Becerra V
Economic evaluation of dabigatran etexilate in stroke prevention in patients with non valvular atrial fibrillation
21st European Stroke Conference (ESC). Lisbon, Portugal. 22-25 may 2012
González-Juanatey JR, Álvarez-Sabin J, Lobos JM, Martínez-Rubio A, Reverter JC, Oyagüez I, González-Rojas N, Becerra V
Análisis coste-efectividad de dabigatrán para la prevención de ictus y embolia sistémica en fibrilación auricular no valvular en España
32 jornadas de Economía de la Salud (AES). Bilbao, España. 15-18 may 2012
Domínguez-Gil A, Alegre A, López A, Oyagüez I, Gutierrez L, Restovic G, Casado MA